Health Emergency Preparedness Task Force: COVID-19 (Coronavirus) Update


Overview of Cases

*Note: The WHO releases a daily situation report reflecting totals as of 10 a.m. CET on the previous day.

Travel Alerts

The CDC issues travel notices based on an assessment of the potential risks associated with traveling to a particular region. The three levels of notices are as follows:

In addition to the travel notices above, the CDC has identified SingaporeTaiwan, and Thailand as destinations with risk of community spread of COVID-19.

Funding Approval

On Friday, President Trump signed an $8 billion emergency funding package to provide emergency funding to combat the COVID-19 outbreak. The Senate passed the bill 96-1 on Thursday, after the House approved with a 415-2 vote on Wednesday afternoon. The bill includes:

Additional Resources

The American Chemistry Council’s (ACC) Center for Biocide Chemistries (CBC) has compiled a list of products that have been pre-approved by the U.S. Environmental Protection Agency (EPA) for use against emerging enveloped viral pathogens and can be used during the COVID-19 outbreak. This product list is not exhaustive but can be used by business owners, health professionals, and the public to identify products suitable for use against COVID-19. See the list of Novel Coronavirus (COVID-19)—Fighting Products.

For more information on ongoing transmission, travel alerts, and preparedness, please visit the CDC Situation Summary.


©2025 Greenberg Traurig, LLP. All rights reserved.
National Law Review, Volume X, Number 67